Ikeda et al. evaluated MET alterations in a variety of tumor types by ctDNA and found that the presence of MET alterations correlated with bone metastases, TP53 and PTEN alterations, and an increased number of overall alterations. The gene discussed is MET; the disease is neoplasm.